NJ Bundred - Concepedia

Author

NJ Bundred

Universitair Ziekenhuis Leuven

Also Known As

Bundred, N, N BUNDRED, N Bundred, N J Bundred, N. Bundred, NJ Bundred

Publications

370

Citations

H-Index

Concepts

All Affiliations

Universitair Ziekenhuis Leuven Universitäts Frauenklinik The Royal Melbourne Hospital German Breast group

About

NJ Bundred is an author at Universitair Ziekenhuis Leuven specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	352
2	Health Sciences	2	2	51
3	Endocrinology	1	1	216
4	Immunology	1	1	34
5	Nephrology	1	1	32

NJ Bundred

Publications

362

Citations

H-Index

Page 1

	Year	Citations
Comparison of the short-term biological effects of 7alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer. J.F.R. Robertson, Robert I. Nicholson, NJ Bundred, PubMed Breast OncologyVersus TamoxifenGynecologyPrimary Breast CancerShort-term Biological Effects	2001	216
Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast Ashu Gandhi, PA Holland, W.F. Knox, British Journal of Cancer Tumor BiologyBreast OncologySignificant ApoptosisMedicinePathology	1998	35
Effects of a pure antiestrogen on apoptosis and proliferation within human breast ductal carcinoma in situ. Ashu Gandhi, PA Holland, W F Knox, PubMed Tumor BiologyPure AeBreast OncologyMedicineImmunology	2000	34
Hypercalcemia and bone resorption in malignancy. J. Walls, NJ Bundred, Anthony Howell PubMed Bone DiseaseNuclear MedicineUrologyBone ResorptionMedicine	1995	32
Abstract P5-11-01: The Effect of Zoledronic Acid on Aromatase Inhibitor Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: The ZO-FAST Study 5-Year Final Follow-Up R. DeBoer, NJ Bundred, Holger Eidtmann, Cancer Research Breast OncologyZol ArmGynecologyPharmacotherapyOsteoporosis	2010	19
S1-3: Long-Term Survival Outcomes among Postmenopausal Women with Hormone Receptor-Positive Early Breast Cancer Receiving Adjuvant Letrozole and Zoledronic Acid: 5-Year Follow-Up of ZO-FAST. Richard de Boer, NJ Bundred, Holger Eidtmann, Cancer Research Breast OncologyCancer ManagementGynecologyDfs BenefitsPharmacotherapy	2011	16
Long term survival following bilateral breast angiosarcoma. NJ Bundred, K.M.A. O'Reilly, Smart Jg PubMed	1989	10

Page 1